UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 268

Sortiert nach

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer

European radiology, 2016-01, Vol.26 (1), p.32-42

2016

Link zum Volltext

Verfügbarkeit prüfen

The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories

Neuroendocrinology, 2017-01, Vol.104 (1), p.85-93

2017

Link zum Volltext

Verfügbarkeit prüfen

The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker

Journal of translational medicine, 2010-11, Vol.8 (1), p.112-112, Article 112

2010

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Heterogeneity

Diagnostics (Basel), 2021-08, Vol.11 (9), p.1555

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience

The oncologist (Dayton, Ohio), 2024-02, Vol.29 (2), p.159-165

2024

Link zum Volltext

Verfügbarkeit prüfen

Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience

European journal of cancer (1990), 2023-04, Vol.183, p.79-89

2023

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and Predictive Biomarkers in Lung Cancer

Cancers, 2021-06, Vol.13 (11), p.2577

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a Hybrid Capture–Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and Processes

The Journal of molecular diagnostics : JMD, 2020-06, Vol.22 (6), p.757-769

2020

Link zum Volltext

Verfügbarkeit prüfen

Basic principles of biobanking: from biological samples to precision medicine for patients

Virchows Archiv : an international journal of pathology, 2021-08, Vol.479 (2), p.233-246

2021

Link zum Volltext

Verfügbarkeit prüfen

Metastatic and non-metastatic lymph nodes: quantification and different distribution of iodine uptake assessed by dual-energy CT

European radiology, 2018-02, Vol.28 (2), p.760-769

2018

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma

Journal of clinical pathology, 2020-11, Vol.73 (11), p.754

2020

Link zum Volltext

Verfügbarkeit prüfen

Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses

Breast cancer research : BCR, 2020-10, Vol.22 (1), p.107-107, Article 107

2020

Link zum Volltext

Verfügbarkeit prüfen

Making the Most of Complexity to Create Opportunities: Comprehensive Genomic Profiling and Molecular Tumor Board for Patients with Non-Small Cell Lung Cancer (NSCLC)

Cancers, 2021-02, Vol.13 (4), p.609

2021

Link zum Volltext

Verfügbarkeit prüfen

Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer

Frontiers in oncology, 2022-05, Vol.12, p.886440-886440

2022

Link zum Volltext

Verfügbarkeit prüfen

Airway Fistula Closure after Stem-Cell Infusion

The New England journal of medicine, 2015-01, Vol.372 (1), p.96-97

2015

Link zum Volltext

Verfügbarkeit prüfen

Stem Cell Transplantation Effectively Occludes Bronchopleural Fistula in an Animal Model

The Annals of thoracic surgery, 2014-02, Vol.97 (2), p.480-483

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology

Expert opinion on biological therapy, 2016-12, Vol.16 (12), p.1479-1489

2016

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: A role for the immune system in advanced laryngeal cancer

Scientific reports, 2021-05, Vol.11 (1), p.9760-9760, Article 9760

2021

Link zum Volltext

Verfügbarkeit prüfen

Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards

Cancers, 2022-06, Vol.14 (13), p.3193

2022

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma

Clinical cancer research, 2013-11, Vol.19 (22), p.6261-6271

2013

Link zum Volltext

Verfügbarkeit prüfen

An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers

Clinical cancer research, 2017-01, Vol.23 (1), p.62-72

2017

Link zum Volltext

Verfügbarkeit prüfen

Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations

Cancers, 2021-04, Vol.13 (9), p.2172

2021

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis

Endocrine, 2021-04, Vol.72 (1), p.268-278

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)

Cancers, 2020-06, Vol.12 (6), p.1627

2020

Link zum Volltext

Verfügbarkeit prüfen

BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients

Critical reviews in oncology/hematology, 2020-12, Vol.156, p.103118-103118, Article 103118

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 268

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(245)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer

The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories

The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker

Breast Cancer Heterogeneity

Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience

Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience

Diagnostic and Predictive Biomarkers in Lung Cancer

Evaluation of a Hybrid Capture–Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and Processes

Basic principles of biobanking: from biological samples to precision medicine for patients

Metastatic and non-metastatic lymph nodes: quantification and different distribution of iodine uptake assessed by dual-energy CT

SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma

Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses

Making the Most of Complexity to Create Opportunities: Comprehensive Genomic Profiling and Molecular Tumor Board for Patients with Non-Small Cell Lung Cancer (NSCLC)

Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer

Airway Fistula Closure after Stem-Cell Infusion

Stem Cell Transplantation Effectively Occludes Bronchopleural Fistula in an Animal Model

Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology

Author Correction: A role for the immune system in advanced laryngeal cancer

Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards

Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma

An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers

Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations

Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis

Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)

BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients

Suchergebnisse filtern